Glucose sensor membranes for mitigating the foreign body response

Journal of Diabetes Science and Technology

Volumn 5, Issue 5, 2011, Pages 1052-1059

  Koh, Ahyeon ^a   Nichols, Scott P ^a   Schoenfisch, Mark H ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Biocompatibility; Foreign body response; In vivo glucose sensor; Tissue integration

Indexed keywords

BIOMATERIAL;

ARTICLE; BLOOD GLUCOSE MONITORING; FOREIGN BODY REACTION; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; INSTRUMENTATION; MATERIALS TESTING;

BIOCOMPATIBLE MATERIALS; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; FOREIGN-BODY REACTION; MATERIALS TESTING;

EID: 84857387470     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500505     Document Type: Conference Paper

References (90)

1. Wilson GS, Zhang Y. Introduction to the glucose sensing problem. In: Cunningham DD, Stenken JA, eds. In vivo glucose sensing. Hoboken: John Wiley & Sons; 2009.
2. Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31(1):81-110.
3. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86-100.
4. Thomé-Duret V, Gangnerau MN, Zhang Y, Wilson GS, Reach G. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metab. 1996;22(3):174-8.
5. Gerritsen M, Jansen JA, Kros A, Vriezema DM, Sommerdijk NA, Nolte RJ, Lutterman JA, Van Hövell SW, Van der Gaag A. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res. 2001;54(1):69-75.
6. Wilson GS, Hu Y. Enzyme-based biosensors for in vivo measurements. Chem Rev. 2000;100(7):2693-704.
7. Forster J, Morris AS, Shearer JD, Mastrofrancesco B, Inman KC, Lawler RG, Bowen W, Caldwell MD. Glucose uptake and flux through phosphofructokinase in wounded rat skeletal muscle. Am J Physiol. 1989;256(6 Pt 1):E788-97.
8. Zhao QH, McNally AK, Rubin KR, Renier M, Wu Y, Rose-Caprara V, Anderson JM, Hiltner A, Urbanski P, Stokes K. Human plasma alpha 2-macroglobulin promotes in vitro oxidative stress cracking of Pellethane 2363-80A: in vivo and in vitro correlations. J Biomed Mater Res. 1993;27(3):379-88.
9. Anderson JM, Defife K, McNally A, Collier T, Jenney C. Monocyte, macrophage and foreign body giant cell interactions with molecularly engineered surfaces. J Mater Sci Mater Med. 1999;10(10):579-88.
10. Klueh U, Kaur M, Qiao Y, Kreutzer DL. Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. Biomaterials. 2010;31(16):4540-51.
11. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Difusion properties. J Biomed Mater Res. 1997;37(3):401-12.
12. Jablecki M, Gough DA. Simulations of the frequency response of implantable glucose sensors. Anal Chem. 2000;72(8):1853-9.
13. Brodbeck WG, Voskerician G, Ziats NP, Nakayama Y, Matsuda T, Anderson JM. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A. 2003;64(2):320-9.
14. Dinnes DL, Marçal H, Mahler SM, Santerre JP, Labow RS. Material surfaces afect the protein expression patterns of human macrophages: a proteomics approach. J Biomed Mater Res A. 2007;80(4):895-908.
15. Ju YM, Yu B, Koob TJ, Moussy Y, Moussy F. A novel porous collagen scafold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scafold and in vitro sensitivity of the glucose sensor with scafold. J Biomed Mater Res A. 2008;87(1):136-46.
16. Ju YM, Yu B, West L, Moussy Y, Moussy F. A novel porous collagen scafold around an implantable biosensor for improving biocompatibility. II. Long-term in vitro/in vivo sensitivity characteristics of sensors with NDGA- or GA-crosslinked collagen scafolds. J Biomed Mater Res A. 2010;92(2):650-8.
17. Weng L, Romanov A, Rooney J, Chen W. Non-cytotoxic, in situ gelable hydrogels composed of N-carboxyethyl chitosan and oxidized dextran. Biomaterials. 2008;29(29):3905-13.
18. Cai Z, Kim J. Bacterial cellulose/poly(ethylene glycol) composite: characterization and first evaluation of biocompatibility. Cellulose. 2010;17(1):83-91.
19. Helenius G, Bäckdahl H, Bodin A, Nannmark U, Gatenholm P, Risberg B. In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res A. 2006;76(2):431-8.
20. Go DH, Joung YK, Park SY, Park YD, Park KD. Heparin-conjugated star-shaped PLA for improved biocompatibility. J Biomed Mater Res A. 2008;86(3):842-8.
21. Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, De Reu B, Schacht E. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials. 1998;19(18):1677-87.
22. Cadée JA, van Luyn MJ, Brouwer LA, Plantinga JA, van Wachem PB, de Groot CJ, den Otter W, Hennink WE. In vivo biocompatibility of dextran-based hydrogels. J Biomed Mater Res. 2000;50(3):397-404.
23. Wisniewski N, Reichert M. Methods for reducing biosensor membrane biofouling. Colloids Surf B. 2000;18(3-4):197-219.
24. Ishihara K, Nomura H, Mihara T, Kurita K, Iwasaki Y, Nakabayashi N. Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res. 1998;39(2):323-30.
25. Kim K, Kim C, Byun Y. Biostability and biocompatibility of a surface-grafted phospholipid monolayer on a solid substrate. Biomaterials. 2004;25(1):33-41.
26. Sawada S, Sakaki S, Iwasaki Y, Nakabayashi N, Ishihara K. Suppression of the inflammatory response from adherent cells on phospholipid polymers. J Biomed Mater Res A. 2003;64(3):411-6.
27. Turner RF, Harrison DJ, Rajotte RV. Preliminary in vivo biocompatibility studies on perfluorosulphonic acid polymer membranes for biosensor applications. Biomaterials. 1991;12(4):361-8.
28. Mercado RC, Moussy F. In vitro and in vivo mineralization of Nafion membrane used for implantable glucose sensors. Biosens Bioelectron. 1998;13(2):133-45.
29. Moussy F, Harrison DJ, Rajotte RV. A miniaturized Nafion-based glucose sensor: in vitro and in vivo evaluation in dogs. Int J Artif Organs. 1994;17(2):88-94.
30. Jhon MS, Andrade JD. Water and hydrogels. J Biomed Mater Res. 1973;7(6):509-22.
31. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101(7):1869-79.
32. .Yu B, Wang C, Ju YM, West L, Harmon J, Moussy Y, Moussy F. Use of hydrogel coating to improve the performance of implanted glucose sensors. Biosens Bioelectron. 2008;23(8):1278-84.
33. Quinn CA, Connor RE, Heller A. Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. Biomaterials. 1997;18(24):1665-70.
34. .Wang C, Yu B, Knudsen B, Harmon J, Moussy F, Moussy Y. Synthesis and performance of novel hydrogels coatings for implantable glucose sensors. Biomacromolecules. 2008;9(2):561-7.
35. Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings afect the foreign body response. J Biomed Mater Res A. 2007;81(4):858-69.
36. Tipnis R, Vaddiraju S, Jain F, Burgess DJ, Papadimitrakopoulos F. Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. J Diabetes Sci Technol. 2007;1(2):193-200.
37. Vaddiraju S, Singh H, Burgess DJ, Jain FC, Papadimitrakopoulos F. Enhanced glucose sensor linearity using poly(vinyl alcohol) hydrogels. J Diabetes Sci Technol. 2009;3(4):863-74.
38. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res. 1998;42(3):396-402.
39. Hua FJ, Kim GE, Lee JD, Son YK, Lee DS. Macroporous poly(L-lactide) scafold 1. Preparation of a macroporous scafold by liquid - liquid phase separation of a PLLA - dioxane - water system. J Biomed Mater Res. 2002;63(2):161-7.
40. Marshall AJ, Ratner BD. Quantitative characterization of sphere-templated porous biomaterials. AlChE J. 2005;51(4):1221-32.
41. Yang S, Leong KF, Du Z, Chua CK. The design of scafolds for use in tissue engineering. Part 1. Traditional factors. Tissue Eng. 2001;7(6):679-89.
42. Koschwanez HE, Yap FY, Klitzman B, Reichert WM. In vitro and in vivo characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose sensors. J Biomed Mater Res A. 2008;87(3):792-807.
43. Marshall AJ, Irvin CA, Barker T, Sage EH, Hauch KD, Ratner BD. Biomaterials with tightly controlled pore size that promote vascular in-growth. ACS Polym Prepr. 2004;45(2):100-1.
44. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res. 1998;40(4):586-97.
45. Isenhath SN, Fukano Y, Usui ML, Underwood RA, Irvin CA, Marshall AJ, Hauch KD, Ratner BD, Fleckman P, Olerud JE. A mouse model to evaluate the interface between skin and a percutaneous device. J Biomed Mater Res A. 2007;83(4):915-22.
46. Deligianni DD, Katsala N, Ladas S, Sotiropoulou D, Amedee J, Missirlis YF. Efect of surface roughness of the titanium alloy Ti-6Al-4V on human bone marrow cell response and on protein adsorption. Biomaterials. 2001;22(11):1241-51.
47. Roach P, Farrar D, Perry CC. Surface tailoring for controlled protein adsorption: efect of topography at the nanometer scale and chemistry. J Am Chem Soc. 2006;128(12):3939-45.
48. Cao H, McHugh K, Chew SY, Anderson JM. The topographical efect of electrospun nanofibrous scafolds on the in vivo and in vitro foreign body reaction. J Biomed Mater Res A. 2010;93(3):1151-9.
49. Bota PC, Collie AM, Puolakkainen P, Vernon RB, Sage EH, Ratner BD, Stayton PS. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater Res A. 2010;95(2):649-57.
50. Paul NE, Skazik C, Harwardt M, Bartneck M, Denecke B, Klee D, Salber J, Zwadlo-Klarwasser G. Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface. Biomaterials. 2008;29(30):4056-64.
51. Refai AK, Textor M, Brunette DM, Waterfield JD. Efect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. J Biomed Mater Res A. 2004;70(2):194-205.
52. Soskolne WA, Cohen S, Sennerby L, Wennerberg A, Shapira L. The efect of titanium surface roughness on the adhesion of monocytes and their secretion of TNF-alpha and PGE2. Clin Oral Implants Res. 2002;13(1):86-93.
53. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35(9):780-9.
54. .Sung J, Barone PW, Kong H, Strano MS. Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors. Biomaterials. 2009;30(4):622-31.
55. Norton LW, Tegnell E, Toporek SS, Reichert WM. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials. 2005;26(16):3285-97.
56. .Patil SD, Papadmitrakopoulos F, Burgess DJ. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release. 2007;117(1):68-79.
57. Klueh U, Dorsky DI, Kreutzer DL. Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials. 2005;26(10):1155-63.
58. Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF. The efect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. Diabetes Technol Ther. 2004;6(2):137-45.
59. Ward WK, Quinn MJ, Wood MD, Tiekotter KL, Pidikiti S, Gallagher JA. Vascularizing the tissue surrounding a model biosensor: how localized is the efect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)? Biosens Bioelectron. 2003;19(3):155-63.
60. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-76.
61. Klueh U, Dorsky DI, Kreutzer DL. Use of vascular endothelial cell growth factor gene transfer to enhance implantable sensor function in vivo. J Biomed Mater Res A. 2003;67(4):1072-86.
62. El Azab SR, Rosseel PM, de Lange JJ, Groeneveld AB, van Strik R, van Wijk EM, Schefer GJ. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth. 2002;88(4):496-501.
63. Strecker EP, Gabelmann A, Boos I, Lucas C, Xu Z, Haberstroh J, Freudenberg N, Stricker H, Langer M, Betz E. Efect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc Intervent Radiol. 1998;21(6):487-96.
64. Beer HD, Fässler R, Werner S. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam Horm. 2000;59:217-39.
65. Hickey T, Kreutzer D, Burgess DJ, Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res. 2002;61(2):180-7.
66. Patil SD, Papadimitrakopoulos F, Burgess DJ. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther. 2004;6(6):887-97.
67. Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res. 2005;80(2):249-58.
68. Machein MR, Kullmer J, Rönicke V, Machein U, Krieg M, Damert A, Breier G, Risau W, Plate KH. Diferential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol. 1999;25(2):104-12.
69. Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR. Dexamethasone induction of keloid regression through efective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol. 2006;126(6):1264-71.
70. Williams DL. A chemist's view of the nitric oxide story. Org Biomol Chem. 2003;1(3):441-9.
71. Giford R, Batchelor MM, Lee Y, Gokulrangan G, Meyerhof ME, Wilson GS. Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. J Biomed Mater Res A. 2005;75(4):755-66.
72. Shin JH, Schoenfisch MH. Improving the biocompatibility of in vivo sensors via nitric oxide release. Analyst. 2006;131(5):609-15.
73. Wang PG, Xian M, Tang X, Wu X, Wen Z, Cai T, Janczuk AJ. Nitric oxide donors: chemical activities and biological applications. Chem Rev. 2002;102(4):1091-134.
74. Al-Sa'doni HH, Ferro A. S-nitrosothiols as nitric oxide-donors: Chemistry, biology and possible future therapeutic applications. Curr Med Chem. 2004;11(20):2679-90.
75. Hetrick EM, Prichard HL, Klitzman B, Schoenfisch MH. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials. 2007;28(31):4571-80.
76. Nablo BJ, Schoenfisch MH. In vitro cytotoxicity of nitric oxide-releasing sol-gel derived materials. Biomaterials. 2005;26(21):4405-15.
77. Riccio DA, Dobmeier KP, Hetrick EM, Privett BJ, Paul HS, Schoenfisch MH. Nitric oxide-releasing S-nitrosothiol-modified xerogels. Biomaterials. 2009;30(27):4494-502.
78. Hetrick EM, Shin JH, Stasko NA, Johnson CB, Wespe DA, Holmuhamedov E, Schoenfisch MH. Bactericidal eficacy of nitric oxide-releasing silica nanoparticles. ACS Nano. 2008;2(2):235-46.
79. Shin JH, Metzger SK, Schoenfisch MH. Synthesis of nitric oxide-releasing silica nanoparticles. J Am Chem Soc. 2007;129(15):4612-9.
80. .Shin JH, Schoenfisch MH. Inorganic/organic hybrid silica nanoparticles as a nitric oxide delivery scafold. Chem Mater. 2008;20(1):239-49.
81. Stasko NA, Fischer TH, Schoenfisch MH. S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules. 2008;9(3):834-41.
82. .Stasko NA, Schoenfisch MH. Dendrimers as a scafold for nitric oxide release. J Am Chem Soc. 2006;128(25):8265-71.
83. Jo YS, van der Vlies AJ, Gantz J, Thacher TN, Antonijevic S, Cavadini S, Demurtas D, Stergiopulos N, Hubbell JA. Micelles for delivery of nitric oxide. J Am Chem Soc. 2009;131(40):14413-8.
84. .Shin JH, Marxer SM, Schoenfisch MH. Nitric oxide-releasing sol-gel particle/polyurethane glucose biosensors. Anal Chem. 2004;76(15):4543-9.
85. Frost MC, Meyerhof ME. Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles. J Biomed Mater Res A. 2005;72(4):409-19.
86. Coneski PN, Nash JA, Schoenfisch MH. Nitric oxide-releasing electrospun polymer microfibers. ACS Appl Mater Interfaces. 2011;3(2):426-32.
87. Mowery KA, Schoenfisch MH, Saavedra JE, Keefer LK, Meyerhof ME. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials. 2000;21(1):9-21.
88. .Parzuchowski PG, Frost MC, Meyerhof ME. Synthesis and characterization of polymethacrylate-based nitric oxide donors. J Am Chem Soc. 2002;124(41):12182-91.
89. Zhou Z, Meyerhof ME. Polymethacrylate-based nitric oxide donors with pendant N-diazeniumdiolated alkyldiamine moieties: synthesis, characterization, and preparation of nitric oxide releasing polymeric coatings. Biomacromolecules. 2005;6(2):780-9.
90. Nichols SP, Le NN, Klitzman B, Schoenfisch MH. Increased in vivo glucose recovery via nitric oxide release. Anal Chem. 2011;83(4):1180-4.